financetom
Business
financetom
/
Business
/
Royalty Pharma Insider Sold Shares Worth $766,420, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Royalty Pharma Insider Sold Shares Worth $766,420, According to a Recent SEC Filing
Mar 10, 2026 10:47 PM

05:47 PM EST, 12/17/2025 (MT Newswires) -- Marshall Urist, Executive Vice President, Research & Investments, on December 16, 2025, sold 20,000 shares in Royalty Pharma ( RPRX ) for $766,420. Following the Form 4 filing with the SEC, Urist has control over a total of 166,418 Class A ordinary shares of the company, with 7,398 shares held directly and 159,020 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1802768/000183813925000010/xslF345X05/wk-form4_1766011394.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved